Brooklyn Investment Group

Position in ZTS — Zoetis Inc.

CIK 1795705 NEW YORK, NY

Position in ZTS

as of Mar 31, 2026 · filed Apr 29, 2026 Compact

Position Value

$1,760,383

-$55,702 QoQ

Shares Held

14,892

+3.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Brooklyn Investment Group holds $16,769,575 across 17 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	174,896	$3,239,073
2	HLN	Haleon plc	260,541	$2,608,015
3	UTHR	UNITED THERAPEUTICS Corp	3,728	$2,210,629
4	ZTS	Zoetis Inc. This page	14,892	$1,760,383
5	TEVA	Teva Pharmaceutical Industries Ltd	56,904	$1,713,948
6	RDY	Dr Reddys Laboratories Ltd	72,584	$1,005,288
7	NBIX	Neurocrine Biosciences Inc	4,947	$651,717
8	ELAN	Elanco Animal Health Inc	25,358	$606,816

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,760,383	14,892	+3.2%	Shares	Defined	2026-04-29
2025-12-31	$1,816,085	14,434	+58.7%	Shares	Defined	2026-02-12
2025-09-30	$1,330,634	9,094	+0.7%	Shares	Defined	2025-11-14
2025-06-30	$1,408,072	9,029	+127.0%	Shares	Defined	2025-08-14
2025-03-31	$654,977	3,978	+8.8%	Shares	Defined	2025-05-13
2024-12-31	$595,509	3,655	+2.0%	Shares	Defined	2025-01-15
2024-09-30	$700,241	3,584	+9.3%	Shares	Defined	2024-11-13
2024-06-30	$568,620	3,280	0.0%	Shares	Defined	2024-08-12
2024-03-31	$555,008	3,280	-6.7%	Shares	Defined	2024-05-07
2023-12-31	$693,755	3,515	—	Shares	Defined	2024-02-09
No filing history on record for this holder in this stock.